Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "neladalkib"

1 News Found

GSK bets big on oncology with $10.6 billion Nuvalent acquisition
News | June 10, 2026

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio